valerates has been researched along with Hyperlipoproteinemia Type IV in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nash, DT | 1 |
| Berg, K; Børresen, AL; Dahlén, G; Ericson, C; Gillnäs, T | 1 |
| Bilheimer, DW; East, C; Grundy, SM | 1 |
| Idzior-Waluś, B; Jamska, B; Malczewska-Malec, M; Nowacki, G; Sznajd, J | 1 |
| Idzior-Waluś, B; Iwanejko, J; Malczewska-Malec, M; Nowacki, G; Sznajd, J | 1 |
| Breslow, JL; Eisenberg, S; Weintraub, MS | 1 |
| Grundy, SM; Vega, GL | 1 |
| Gartside, PS; Hynd, BA; Kashyap, ML; Saku, K | 1 |
5 trial(s) available for valerates and Hyperlipoproteinemia Type IV
| Article | Year |
|---|---|
Effect of gemfibrozil on serum lipid levels.
Topics: Cholesterol; Clinical Trials as Topic; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates; Xylenes | 1980 |
Combination drug therapy for familial combined hyperlipidemia.
Topics: Adult; Cholelithiasis; Colestipol; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Pentanoic Acids; Polyamines; Random Allocation; Ultrasonography; Valerates | 1988 |
[Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. I. Changes in lipid levels after treatment (the "net" reduction)].
Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Double-Blind Method; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates | 1987 |
[Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. II. Relation between the results of treatment and type of dyslipoproteinemia].
Topics: Apolipoproteins; Cholesterol; Clinical Trials as Topic; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Pentanoic Acids; Triglycerides; Valerates | 1987 |
Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. Effects on metabolism of low-density lipoproteins.
Topics: Adult; Aged; Apolipoproteins B; Cholesterol, LDL; Coronary Disease; Gemfibrozil; Humans; Hyperlipidemias; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates | 1985 |
3 other study(ies) available for valerates and Hyperlipoproteinemia Type IV
| Article | Year |
|---|---|
Gemfibrozil--a new lipid lowering agent.
Topics: Cholesterol; Clofibrate; Dose-Response Relationship, Drug; Double-Blind Method; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Pentanoic Acids; Triglycerides; Valerates; Xylenes | 1980 |
Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.
Topics: Cholestyramine Resin; Chylomicrons; Dietary Fats; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Lipoproteins; Male; Pentanoic Acids; Triglycerides; Valerates; Vitamin A | 1987 |
Mechanism of action of gemfibrozil on lipoprotein metabolism.
Topics: Apolipoprotein A-I; Apolipoprotein A-II; Apolipoprotein C-II; Apolipoprotein C-III; Apolipoproteins A; Apolipoproteins C; Gemfibrozil; Humans; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Kinetics; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Particle Size; Pentanoic Acids; Triglycerides; Valerates | 1985 |